BECTON DICKINSON & CO - BDX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 06, 2026 | EVP and Chief People Officer | F | D | 1,146.0 | 0.0 | 0.0 | 23,966.0 | View | |
| Mar 27, 2026 | EVP, Chief Revenue Officer | S | D | 75.0 | 156.83 | 11,762.25 | 21,233.0 | View | |
| Mar 17, 2026 | EVP and General Counsel | A | A | 7,492.0 | 0.0 | 0.0 | 7,492.0 | View | |
| Mar 04, 2026 | Interim CFO | A | A | 931.0 | 0.0 | 0.0 | 6,510.0 | View | |
| Mar 04, 2026 | SVP Controller & CAO | A | A | 931.0 | 0.0 | 0.0 | 3,323.0 | View | |
| Feb 27, 2026 | EVP, Chief Revenue Officer | S | D | 75.0 | 181.84 | 13,638.0 | 21,308.0 | View | |
| Feb 18, 2026 | — | S | D | 953.0 | 182.61 | 174,027.33 | 36,763.0 | View | |
| Feb 11, 2026 | — | J | D | 284,771,350.0 | — | — | 0.0 | View | |
| Feb 05, 2026 | — | A | A | 30.0 | 201.91 | 6,057.3 | 1,714.0 | View | |
| Feb 05, 2026 | — | A | A | 100.0 | 201.91 | 20,191.0 | 100.0 | View | |
| Feb 05, 2026 | — | A | A | 272.0 | 201.91 | 54,919.52 | 11,649.0 | View | |
| Jan 29, 2026 | — | A | A | 1,098.0 | 0.0 | 0.0 | 1,279.0 | View | |
| Jan 29, 2026 | — | A | A | 1,098.0 | 0.0 | 0.0 | 3,391.0 | View | |
| Jan 29, 2026 | — | A | A | 1,098.0 | 0.0 | 0.0 | 37,716.0 | View | |
| Jan 29, 2026 | — | A | A | 1,098.0 | 0.0 | 0.0 | 59,160.0 | View | |
| Jan 29, 2026 | — | A | A | 1,098.0 | 0.0 | 0.0 | 24,304.0 | View | |
| Jan 29, 2026 | — | A | A | 1,098.0 | 0.0 | 0.0 | 1,279.0 | View | |
| Jan 29, 2026 | — | A | A | 1,098.0 | 0.0 | 0.0 | 4,663.0 | View | |
| Jan 29, 2026 | — | A | A | 1,098.0 | 0.0 | 0.0 | 7,159.0 | View | |
| Jan 29, 2026 | — | A | A | 1,098.0 | 0.0 | 0.0 | 5,018.0 | View | |
| Jan 29, 2026 | — | A | A | 1,098.0 | 0.0 | 0.0 | 10,423.0 | View | |
| Jan 29, 2026 | — | A | A | 1,098.0 | 0.0 | 0.0 | 9,143.0 | View | |
| Jan 28, 2026 | EVP, CRO & Pres. Life Sciences | S | D | 75.0 | 202.73 | 15,204.75 | 16,431.0 | View | |
| Jan 23, 2026 | SVP Controller & CAO | F | D | 84.0 | 0.0 | 0.0 | 1,832.0 | View | |
| Jan 16, 2026 | EVP & Pres Med.Essntl&BioPharm | M | D | 3,054.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 16, 2026 | EVP & Pres Med.Essntl&BioPharm | S | D | 1,010.0 | 206.54 | 208,605.4 | 12,095.0 | View | |
| Jan 16, 2026 | EVP & Pres Med.Essntl&BioPharm | S | D | 600.0 | 209.0 | 125,400.0 | 13,105.0 | View | |
| Jan 16, 2026 | EVP & Pres Med.Essntl&BioPharm | D | D | 2,454.0 | 209.0 | 512,886.0 | 13,705.0 | View | |
| Jan 16, 2026 | EVP & Pres Med.Essntl&BioPharm | M | A | 3,054.0 | 167.91 | 512,797.14 | 16,159.0 | View | |
| Jan 06, 2026 | EVP and Chief ISC Officer | F | D | 44.0 | 0.0 | 0.0 | 8,926.0 | View | |
| Dec 29, 2025 | EVP, CRO & Pres. Life Sciences | S | D | 74.0 | 196.08 | 14,509.92 | 16,506.0 | View | |
| Dec 17, 2025 | EVP & Pres Med.Essntl&BioPharm | S | D | 629.0 | 196.03 | 123,302.87 | 13,105.0 | View | |
| Dec 02, 2025 | — | A | A | 180.0 | 0.0 | 0.0 | 180.0 | View | |
| Dec 02, 2025 | EVP, CRO & Pres. Life Sciences | S | D | 75.0 | 193.36 | 14,502.0 | 16,580.0 | View | |
| Dec 02, 2025 | — | A | A | 180.0 | 0.0 | 0.0 | 180.0 | View | |
| Dec 01, 2025 | SVPController & Chief Acct Off | A | A | 1,234.0 | 0.0 | 0.0 | 1,916.0 | View | |
| Dec 01, 2025 | Chairman, CEO and President | A | A | 165,581.0 | 0.0 | 0.0 | 165,581.0 | View | |
| Dec 01, 2025 | Chairman, CEO and President | F | D | 17,421.0 | 0.0 | 0.0 | 105,471.0 | View | |
| Dec 01, 2025 | Chairman, CEO and President | A | A | 22,521.0 | 0.0 | 0.0 | 122,892.0 | View | |
| Dec 01, 2025 | EVP & President Connected Care | A | A | 9,530.0 | 0.0 | 0.0 | 21,751.0 | View | |
| Dec 01, 2025 | EVP & President Interventional | F | D | 1,719.0 | 0.0 | 0.0 | 13,849.0 | View | |
| Dec 01, 2025 | EVP & President Interventional | A | A | 2,385.0 | 0.0 | 0.0 | 15,568.0 | View | |
| Dec 01, 2025 | EVP & President Interventional | A | A | 6,447.0 | 0.0 | 0.0 | 13,183.0 | View | |
| Dec 01, 2025 | EVP & Chief Financial Officer | F | D | 4,245.0 | 0.0 | 0.0 | 22,982.0 | View | |
| Dec 01, 2025 | EVP & Chief Financial Officer | A | A | 6,006.0 | 0.0 | 0.0 | 27,227.0 | View | |
| Dec 01, 2025 | EVP, CRO & Pres. Life Sciences | F | D | 419.0 | 0.0 | 0.0 | 16,655.0 | View | |
| Dec 01, 2025 | EVP, CRO & Pres. Life Sciences | A | A | 8,829.0 | 0.0 | 0.0 | 17,074.0 | View | |
| Dec 01, 2025 | EVP & Pres Med.Essntl&BioPharm | F | D | 1,769.0 | 0.0 | 0.0 | 13,734.0 | View | |
| Dec 01, 2025 | EVP & Pres Med.Essntl&BioPharm | A | A | 3,048.0 | 0.0 | 0.0 | 15,503.0 | View | |
| Dec 01, 2025 | EVP & Pres Med.Essntl&BioPharm | A | A | 7,568.0 | 0.0 | 0.0 | 12,455.0 | View | |
| Dec 01, 2025 | EVP and President, EMEA | F | D | 138.0 | 0.0 | 0.0 | 17,222.0 | View | |
| Dec 01, 2025 | EVP and President, EMEA | A | A | 1,237.0 | 0.0 | 0.0 | 17,360.0 | View | |
| Dec 01, 2025 | EVP and President, EMEA | A | A | 1,906.0 | 0.0 | 0.0 | 16,123.0 | View | |
| Dec 01, 2025 | EVP and Chief People Officer | F | D | 2,454.0 | 0.0 | 0.0 | 21,326.0 | View | |
| Dec 01, 2025 | EVP and Chief People Officer | A | A | 3,525.0 | 0.0 | 0.0 | 23,780.0 | View | |
| Dec 01, 2025 | EVP and Chief People Officer | A | A | 6,727.0 | 0.0 | 0.0 | 20,255.0 | View | |
| Dec 01, 2025 | EVP and Chief ISC Officer | F | D | 134.0 | 0.0 | 0.0 | 8,970.0 | View | |
| Dec 01, 2025 | EVP and Chief ISC Officer | A | A | 1,025.0 | 0.0 | 0.0 | 9,104.0 | View | |
| Dec 01, 2025 | EVP and Chief ISC Officer | A | A | 3,504.0 | 0.0 | 0.0 | 8,079.0 | View | |
| Dec 01, 2025 | EVP & President, Greater Asia | A | A | 708.0 | 0.0 | 0.0 | 5,763.0 | View | |
| Dec 01, 2025 | EVP & President, Greater Asia | A | A | 2,208.0 | 0.0 | 0.0 | 5,055.0 | View | |
| Nov 07, 2025 | — | S | D | 217.0 | 176.58 | 38,317.86 | 35,816.0 | View | |
| Nov 04, 2025 | — | A | A | 34.0 | 178.71 | 6,076.14 | 1,675.0 | View | |
| Nov 04, 2025 | — | A | A | 168.0 | 178.71 | 30,023.28 | 11,316.0 | View | |
| Oct 28, 2025 | EVP & President, Life Sciences | S | D | 57.0 | 186.01 | 10,602.57 | 8,245.0 | View |